ARLINGTON, Virginia, Dec. 12 -- The Healthcare Distribution Alliance issued the following news release:

Specialty pharmaceutical distributors expect products in the autoimmune/immune and ophthalmology categories to rise in importance over the next 12 months, followed by oncology, central nervous system and inflammatory products. The findings were published in the HDA Research Foundation's 2017 edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products